A citation-based method for searching scientific literature

Kimberly M Kelly, Lee Ellington, Nancy Schoenberg, Parul Agarwal, Thomas Jackson, Stephanie Dickinson, Jame Abraham, Electra D Paskett, Howard Leventhal, Michael Andrykowski. J Genet Couns 2014
Times Cited: 9







List of co-cited articles
19 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Genetic counseling content: How does it impact health behavior?
Kimberly M Kelly, Lee Ellington, Nancy Schoenberg, Thomas Jackson, Stephanie Dickinson, Kyle Porter, Howard Leventhal, Michael Andrykowski. J Behav Med 2015
8
37


Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.
Amy Finch, Mario Beiner, Jan Lubinski, Henry T Lynch, Pal Moller, Barry Rosen, Joan Murphy, Parviz Ghadirian, Eitan Friedman, William D Foulkes,[...]. JAMA 2006
394
22

Long-term outcomes of genetic counseling in women at increased risk of developing hereditary breast cancer.
B Meiser, P N Butow, A L Barratt, V Schnieden, M Gattas, J Kirk, C Gaff, G Suthers, K Tucker. Patient Educ Couns 2001
68
22

American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility.
Mark E Robson, Courtney D Storm, Jeffrey Weitzel, Dana S Wollins, Kenneth Offit. J Clin Oncol 2010
298
22

Cancer genetics knowledge and beliefs and receipt of results in Ashkenazi Jewish individuals receiving counseling for BRCA1/2 mutations.
Kimberly Kelly, Howard Leventhal, Monica Marvin, Deborah Toppmeyer, Jill Baran, Marvin Schwalb. Cancer Control 2004
28
22

Essential elements of genetic cancer risk assessment, counseling, and testing: updated recommendations of the National Society of Genetic Counselors.
Bronson D Riley, Julie O Culver, Cécile Skrzynia, Leigha A Senter, June A Peters, Josephine W Costalas, Faith Callif-Daley, Sherry C Grumet, Katherine S Hunt, Rebecca S Nagy,[...]. J Genet Couns 2012
187
22

Goals of genetic counseling.
B B Biesecker. Clin Genet 2001
119
22

Development and validation of a Breast Cancer Genetic Counseling Knowledge Questionnaire.
Joel Erblich, Karen Brown, Youngmee Kim, Heiddis B Valdimarsdottir, Barbara E Livingston, Dana H Bovbjerg. Patient Educ Couns 2005
50
22

Disparities in uptake of BRCA1/2 genetic testing in a randomized trial of telephone counseling.
Morgan Butrick, Scott Kelly, Beth N Peshkin, George Luta, Rachel Nusbaum, Gillian W Hooker, Kristi Graves, Lisa Feeley, Claudine Isaacs, Heiddis B Valdimarsdottir,[...]. Genet Med 2015
61
22

The associations of clinicians' implicit attitudes about race with medical visit communication and patient ratings of interpersonal care.
Lisa A Cooper, Debra L Roter, Kathryn A Carson, Mary Catherine Beach, Janice A Sabin, Anthony G Greenwald, Thomas S Inui. Am J Public Health 2012
360
22

Clinicians' implicit ethnic/racial bias and perceptions of care among Black and Latino patients.
Irene V Blair, John F Steiner, Diane L Fairclough, Rebecca Hanratty, David W Price, Holen K Hirsh, Leslie A Wright, Michael Bronsert, Elhum Karimkhani, David J Magid,[...]. Ann Fam Med 2013
167
22

Genetic counselors' implicit racial attitudes and their relationship to communication.
Kendra L Schaa, Debra L Roter, Barbara B Biesecker, Lisa A Cooper, Lori H Erby. Health Psychol 2015
25
22

A systematic review of perceived risks, psychological and behavioral impacts of genetic testing.
Jodi T Heshka, Crystal Palleschi, Heather Howley, Brenda Wilson, Philip S Wells. Genet Med 2008
223
22

The impact of proband mediated information dissemination in families with a BRCA1/2 gene mutation.
E Sermijn, G Goelen, E Teugels, L Kaufman, M Bonduelle, B Neyns, B Poppe, A De Paepe, J De Grève. J Med Genet 2004
45
22

Measuring emotional expression with the Linguistic Inquiry and Word Count.
Jeffrey H Kahn, Renée M Tobin, Audra E Massey, Jennifer A Anderson. Am J Psychol 2007
93
22

The Genetic Counseling Video Project (GCVP): models of practice.
D Roter, L Ellington, L Hamby Erby, S Larson, W Dudley. Am J Med Genet C Semin Med Genet 2006
78
22


Communication in genetic counseling: cognitive and emotional processing.
Lee Ellington, Kimberly M Kelly, Maija Reblin, Seth Latimer, Debra Roter. Health Commun 2011
28
22

Bilateral prophylactic oophorectomy and ovarian cancer screening following BRCA1/BRCA2 mutation testing.
Marc D Schwartz, Elizabeth Kaufman, Beth N Peshkin, Claudine Isaacs, Chanita Hughes, Tiffani DeMarco, Clinton Finch, Caryn Lerman. J Clin Oncol 2003
95
11

The decision to test in women receiving genetic counseling for BRCA1 and BRCA2 mutations.
Kimberly Kelly, Howard Leventhal, Michael Andrykowski, Deborah Toppmeyer, Judie Much, James Dermody, Monica Marvin, Jill Baran, Marvin Schwalb. J Genet Couns 2004
19
11

Enhanced counseling for women undergoing BRCA1/2 testing: impact on subsequent decision making about risk reduction behaviors.
Suzanne M Miller, Pagona Roussi, Mary B Daly, Joanne S Buzaglo, Kerry Sherman, Andrew K Godwin, Andrew Balshem, Margaret E Atchison. Health Educ Behav 2005
32
11

Risk-reducing mastectomy in BRCA1/2 mutation carriers: factors influencing uptake and timing.
Catheleine M van Driel, Yassir Eltahir, Jakob de Vries, Jan P Jaspers, Jan C Oosterwijk, Marian J Mourits, Geertruida H de Bock. Maturitas 2014
13
11

Early detection of breast and ovarian cancer in families with BRCA mutations.
H F A Vasen, E Tesfay, H Boonstra, M J E Mourits, E Rutgers, R Verheyen, J Oosterwijk, L Beex. Eur J Cancer 2005
52
11

Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer.
L C Hartmann, D J Schaid, J E Woods, T P Crotty, J L Myers, P G Arnold, P M Petty, T A Sellers, J L Johnson, S K McDonnell,[...]. N Engl J Med 1999
919
11

A randomized trial of breast cancer risk counseling: the impact on self-reported mammography use.
M D Schwartz, B K Rimer, M Daly, C Sands, C Lerman. Am J Public Health 1999
52
11

Utilization of breast cancer screening in a clinically based sample of women after BRCA1/2 testing.
Beth N Peshkin, Marc D Schwartz, Claudine Isaacs, Chanita Hughes, David Main, Caryn Lerman. Cancer Epidemiol Biomarkers Prev 2002
47
11


Risk reduction behaviors and provider communication following genetic counseling and BRCA1 mutation testing in an African American kindred.
Anita Yeomans Kinney, Sara Ellis Simonsen, Bonnie Jeanne Baty, Diptasri Mandal, Susan L Neuhausen, Kate Seggar, Richard Holubkov, Lindsey Bloor, Ken Smith. J Genet Couns 2006
35
11

Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families.
P Tonin, B Weber, K Offit, F Couch, T R Rebbeck, S Neuhausen, A K Godwin, M Daly, J Wagner-Costalos, D Berman,[...]. Nat Med 1996
233
11


Long-term outcomes of BRCA1/BRCA2 testing: risk reduction and surveillance.
Marc D Schwartz, Claudine Isaacs, Kristi D Graves, Elizabeth Poggi, Beth N Peshkin, Christy Gell, Clinton Finch, Scott Kelly, Kathryn L Taylor, Lauren Perley. Cancer 2012
93
11

The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%.
C Oddoux, J P Struewing, C M Clayton, S Neuhausen, L C Brody, M Kaback, B Haas, L Norton, P Borgen, S Jhanwar,[...]. Nat Genet 1996
298
11



Breast and ovarian cancer screening of non-carriers from BRCA1/2 mutation-positive families: 2-year follow-up of cohorts from France and Quebec.
Michel Dorval, Catherine Noguès, Pascaline Berthet, Jocelyne Chiquette, Marion Gauthier-Villars, Christine Lasset, Claude Picard, Marie Plante, Jacques Simard, Claire Julian-Reynier. Eur J Hum Genet 2011
14
11

Genetic counseling, cancer screening, breast cancer characteristics, and general health among a diverse population of BRCA genetic testers.
Mary S Beattie, Kelli Copeland, Julia Fehniger, Eleanor Cheung, Galen Joseph, Robin Lee, Judith Luce. J Health Care Poor Underserved 2013
3
33

Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.
Sepideh Saadatmand, Madeleine M A Tilanus-Linthorst, Emiel J T Rutgers, Nicoline Hoogerbrugge, Jan C Oosterwijk, Rob A E M Tollenaar, Maartje Hooning, Claudette E Loo, Inge-Marie Obdeijn, Eveline A M Heijnsdijk,[...]. J Natl Cancer Inst 2013
45
11



Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer.
M G FitzGerald, D J MacDonald, M Krainer, I Hoover, E O'Neil, H Unsal, S Silva-Arrieto, D M Finkelstein, P Beer-Romero, C Englert,[...]. N Engl J Med 1996
335
11


Exploring genetic counseling communication patterns: the role of teaching and counseling approaches.
Lee Ellington, Bonnie J Baty, Jamie McDonald, Vickie Venne, Adrian Musters, Debra Roter, William Dudley, Robert T Croyle. J Genet Couns 2006
29
11

Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers.
Lauren Scheuer, Noah Kauff, Mark Robson, Bridget Kelly, Richard Barakat, Jaya Satagopan, Nathan Ellis, Martee Hensley, Jeff Boyd, Patrick Borgen,[...]. J Clin Oncol 2002
307
11

Personal meaning of human papillomavirus and Pap test results in adolescent and young adult women.
Jessica A Kahn, Gail B Slap, David I Bernstein, Abbigail M Tissot, Linda M Kollar, Paula A Hillard, Susan L Rosenthal. Health Psychol 2007
66
11

Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing.
C Lerman, C Hughes, R T Croyle, D Main, C Durham, C Snyder, A Bonney, J F Lynch, S A Narod, H T Lynch. Prev Med 2000
184
11

Impact of genetic testing for breast-ovarian cancer susceptibility.
Starlene Loader, Cleveland G Shields, Peter T Rowley. Genet Test 2004
26
11

One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery).
Litanja N Lodder, Petra G Frets, R Willem Trijsburg, E Johanna Meijers-Heijboer, Jan G M Klijn, Caroline Seynaeve, Albertus N van Geel, Madeleine M A Tilanus, Carina C M Bartels, Leon C Verhoog,[...]. Breast Cancer Res Treat 2002
128
11




Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.